These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23907913)

  • 41. Cardiology patient pages. Cardioversion.
    Shea JB; Maisel WH
    Circulation; 2002 Nov; 106(22):e176-8. PubMed ID: 12451016
    [No Abstract]   [Full Text] [Related]  

  • 42. Atrial fibrillation.
    Campbell RW
    Eur Heart J; 1998 May; 19 Suppl E():E41-5, E60-3. PubMed ID: 9717024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increase in QT/QTc dispersion after low energy cardioversion of chronic persistent atrial fibrillation.
    Boriani G; Valzania C; Biffi M; Corazza I; Camanini C; Martignani C; Bacchi L; Zannoli R; Branzi A
    Int J Cardiol; 2004 Jun; 95(2-3):245-50. PubMed ID: 15193827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rate vs. rhythm control in patients with atrial fibrillation--an updated meta-analysis of 10 randomized controlled trials.
    Chen S; Dong Y; Fan J; Yin Y
    Int J Cardiol; 2011 Nov; 153(1):96-8. PubMed ID: 21963208
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M; Darpö B; Ostergren J; Rosenqvist M
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
    Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Class-1C drugs for oral loading in the cardioversion of paroxysmal atrial fibrillation].
    Capucci A; Rosi A; Villani GQ; Aschieri D; Piepoli M
    G Ital Cardiol; 1998 Dec; 28(12):1422-30. PubMed ID: 9887399
    [No Abstract]   [Full Text] [Related]  

  • 48. [Internal atrial defibrillation after failure of attempted pharmacological and electrical cardioversion. Mid- and long-term outcome].
    Larlet JM; Mansourati J; Verdun F; Guillo P; Maheu B; Blanc JJ
    Arch Mal Coeur Vaiss; 1997 Sep; 90(9):1271-5. PubMed ID: 9488774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rhythm control and cardioversion.
    Sulke N; Sayers F; Lip GY;
    Heart; 2007 Jan; 93(1):29-34. PubMed ID: 16963490
    [No Abstract]   [Full Text] [Related]  

  • 50. [The prediction of atrial fibrillation recurrence after electrical cardioversion with P wave signal averaged EKG].
    Budeus M; Hennersdorf M; Perings C; Strauer BE
    Z Kardiol; 2004 Jun; 93(6):474-8. PubMed ID: 15252741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Signal-averaged P wave reflects change in atrial electrophysiological substrate afforded by verapamil following cardioversion from atrial fibrillation.
    Redfearn DP; Skanes AC; Lane J; Stafford PJ
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1089-95. PubMed ID: 17038141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of sinus rhythm stability after external electric cardioversion in patients with paroxysmal fibrillar arrhythmia].
    Kliuzhev VM; Ardashev VN; Ipatov PV; Ardashev AV; Novosel'skiĭ PA; Sablin BM
    Voen Med Zh; 2004 Mar; 325(3):34-7. PubMed ID: 15112409
    [No Abstract]   [Full Text] [Related]  

  • 53. Prediction of cardiac rhythm 1 year following cardioversion for atrial fibrillation.
    Hamid AK; Richards AM; Crozier IG; Lainchbury JG; Melton I; Bridgman PG; Palmer SC; Frampton CM; Nicholls MG
    N Z Med J; 2011 Sep; 124(1343):48-56. PubMed ID: 21964013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atrial fibrillation.
    Griffith KE; Pye M
    BMJ; 2008 Jul; 337():a475. PubMed ID: 18653632
    [No Abstract]   [Full Text] [Related]  

  • 55. Management of atrial fibrillation in the acute setting.
    Chenoweth J; Diercks DB
    Curr Opin Crit Care; 2012 Aug; 18(4):333-40. PubMed ID: 22622515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
    Hayashi M; Tanaka K; Kato T; Morita N; Sato N; Yasutake M; Kobayashi Y; Takano T
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):740-7. PubMed ID: 16050832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [How I treat... a patient with auricular fibrillation (1)].
    Soyeur D
    Rev Med Liege; 1995 Jul; 50(7):308-9. PubMed ID: 7624678
    [No Abstract]   [Full Text] [Related]  

  • 58. The optimal technique for electrical cardioversion of atrial fibrillation.
    Ewy GA
    Clin Cardiol; 1994 Feb; 17(2):79-84. PubMed ID: 8162630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Termination of paroxysm of atrial fibrillation conversion using oral propafenone after unsuccessful electrical cardioversion].
    Kupriianova OG; Pavlov AV; Vaniev SB; Doshchitsin VL
    Kardiologiia; 2012; 52(4):95-6. PubMed ID: 22839523
    [No Abstract]   [Full Text] [Related]  

  • 60. Determinants of sinus rhythm maintenance in patients with early-persistent atrial fibrillation and heart failure.
    de With RR; Rienstra M; Crijns HJGM; Van Gelder IC;
    Clin Res Cardiol; 2020 Jun; 109(6):787-789. PubMed ID: 31784901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.